Single answer
Is Aspire Biopharma Holdings Inc (ASBP) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
Aspire Biopharma Holdings Inc is a biotechnology company specializing in advanced diagnostic solutions and molecular testing The company focuses on developing highprecision assays for disease detection leveraging cuttingedge research in genetics and biochemistry to support healthcare and life sciences industries
Website: https://aspirebiolabs.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 3.59. Cash flow to debt ratio: -0.41. Net profit margin: -1,478,840.00%. Inflation risk score: high (1.00/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Aspire Biopharma Holdings Inc is $8.4M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Aspire Biopharma Holdings Inc 10 years ago, but if you had invested on 2025-01-24 when the price was $12.11, you would have made a loss of $11.97 per share or 98.83%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.